A roadmap for research on self-managed abortion in the United States

A roadmap for research on self-managed abortion in the United States
(Posted August 29 2018)

Advancing New Standards in Reproductive Health (ANSIRH), Gynuity Health Projects, and Ibis Reproductive Health. A roadmap for research on self-managed abortion in the United States. August 2018.

Media coverage and research data show a growing awareness of the option to self-manage (or self-induce or self-source) abortion outside of the formal health care system; we are learning more about people’s experiences with self-managed abortion, and how often people choose this option in the United States. Recent evidence indicates between one and seven percent of abortion patients (see below) have taken or done something to try to end their current pregnancy. In addition, in 2015, there were more than 700,000 Google searches using terms related to self-induced abortion in the United States. The reasons women attempt to self-manage an abortion are varied, but they are often related to barriers accessing clinic-based care, as well as a preference for self-care.

Continued: https://ibisreproductivehealth.org/publications/roadmap-research-self-managed-abortion-united-states

Read more

Telemedicine Could Help Fill the Gaps in America’s Abortion Care

Telemedicine Could Help Fill the Gaps in America's Abortion Care

Author: Garnet Henderson
Aug 7, 2018

Imagine a woman in Lubbock, Texas, who just found out that she's pregnant. She wants an abortion, but Lubbock is one of 27 abortion deserts in the US: The nearest clinic is 308 miles away in Fort Worth, forcing her to take time off from work, pay for travel, and likely arrange childcare to get there. She’s less than 10 weeks along, so she’s a candidate for medication abortion—which could, theoretically, be completed in the privacy of her home. But Texas requires that the FDA protocol for medication abortion be followed to the letter. She’ll have to return to the clinic within one to two weeks for a follow-up visit, despite evidence that an in-person follow-up is unnecessary.

What if, instead, she could video chat with a doctor, pick up a prescription from her regular pharmacy, and manage her own abortion with on-call medical support—a telemedicine abortion?

Continued: https://www.wired.com/story/telemedicine-could-help-fill-the-gaps-in-americas-abortion-care/

Read more

USA – How technology could preserve abortion rights

How technology could preserve abortion rights
Telemedicine prescriptions could undercut state abortion restrictions.

By MOHANA RAVINDRANATH and RENUKA RAYASAM
07/29/2018

Abortion rights advocates are exploring how technology might preserve or even expand women’s access to abortion if the Supreme Court scales back Roe v. Wade.

A nonprofit group is testing whether it's safe to let women take abortion pills in their own homes after taking screening tests and consulting with a doctor on their phones or computers. Because the study is part of an FDA clinical trial, the group isn’t bound by current rules requiring the drugs be administered in a doctor’s office or clinic.

Continued: https://www.politico.com/story/2018/07/29/abortion-rights-technology-telemedicine-prescriptions-693328

Read more

USA – Self-Induced Abortions Shouldn’t Be A Crime, Mass. Medical Society Says

Self-Induced Abortions Shouldn't Be A Crime, Mass. Medical Society Says

May 07, 2018
Chelsea Conaboy and Carey Goldberg

At its latest meeting, the Massachusetts Medical Society took a new stand: Women who attempt to end a pregnancy on their own should not be considered criminals.

Self-induced abortion is explicitly banned in seven states, and more have laws on the books that could be used to prosecute women for self-induction, according to a recent report.

Continued: http://www.wbur.org/commonhealth/2018/05/07/mass-medical-society-self-induced-abortion

Read more

Revised and expanded guidance on misoprostol-only recommended regimens

Revised and expanded guidance on misoprostol-only recommended regimens
by International Campaign for Women's Right to Safe Abortion
July 14, 2017

The International Federation of Gynecology and Obstetrics (FIGO) has updated its guidance on misoprostol-only regimens for several obstetric and gynaecologic indications. The “FIGO Misoprostol-only Recommended Regimens 2017” chart – published in the International Journal of Gynecology and Obstetrics, accompanied by a commentary – is the result of extensive collaboration between an international expert group, including Gynuity Health Projects. The chart, divided by stages of pregnancy, provides recommendations for dosages and routes of administration for misoprostol use in obstetrics and gynaecology, including: medically induced abortion, medical management of miscarriage, cervical preparation for surgical abortion, fetal death, induction of labour, and management of post-partum haemorrhage (PPH).

Gynuity welcomes the guidance and hopes the chart will be widely disseminated and used by a full range of providers. We support the development and implementation of evidence-based policy and programs to broaden access and availability of misoprostol for each of its women’s health indications.

Article+ chart in PDF format are at: International Journal of Gynecology and Obstetrics

The chart is also available in French, Spanish and Portuguese.

SOURCE: Gynuity Health Projects News, 23 June 2017 ; INFOGRAPHIC

-------------------------------
Source: International Campaign for Women's Right to Safe Abortion

Read more

INVIMA approves mifepristone for abortion in Colombia

INVIMA approves mifepristone for abortion in Colombia
by Safe Abortion
March 31, 2017

On 3 March 2017,  it was announced that Colombia’s Instituto Nacional de Vigilancia de Medicamentos y Alimentos (National Food and Drug Surveillance Institute, INVIMA) had approved the registration of mifepristone in Colombia for use in combination with misoprostol for induced abortion.

According to the Gynuity Health Projects website, mifepristone has been available (up to June 2016) only in Guyana and Uruguay in South America.

Profamilia, Colombia’s national family planning organisation, hope to begin providing the combination method in the second quarter of this year according to Marta Royo, Profamilia’s Executive Director.

Royo reports that in March 2012 Profamilia started all the procedures required in order to introduce mifepristone in Colombia: “It took five years and tons of paperwork, meetings and lobbying, she said, but we made it!!!! We are thrilled at INVIMA´s granting of approval but to be honest, also a little bit scared…. I won’t truly believed it until I see Mifepristona in Profamilia´s clinics and of course other clinics as well.”

SOURCES: El Espectador, 3 March 2017 ; E-mail from Marta Royo, 22 March 2017

----------------------
Source: International Campaign for Women's Right to Safe Abortion: http://www.safeabortionwomensright.org/invima-approves-mifepristone-for-abortion-in-colombia/

Read more

U.S.: FDA urged to let abortion pill be sold at pharmacies

FDA urged to let abortion pill be sold at pharmacies

Posted: Wednesday, February 22, 2017
Associated Press

NEW YORK - The so-called abortion pill — now dispensed only in clinics, hospitals and doctors' offices — should be made available by prescription in pharmacies across the U.S., according to a group of doctors and public health experts urging an end to tough federal restrictions on the drug.

The appeal to the Food and Drug Administration came in a commentary published Wednesday in the New England Journal of Medicine. Among the 10 co-authors were doctors and academics from Stanford, Princeton and Columbia universities, as well as leaders of major reproductive-health organizations.

Continued at source: Chronicle Journal: http://www.chroniclejournal.com/life/health/fda-urged-to-let-abortion-pill-be-sold-at-pharmacies/article_7c2f39d3-1afe-56b1-99b7-f0a61474e46b.html

Read more